These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 11426537)
1. Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia. Minden MD; Dimitroulakos J; Nohynek D; Penn LZ Leuk Lymphoma; 2001 Feb; 40(5-6):659-62. PubMed ID: 11426537 [TBL] [Abstract][Full Text] [Related]
2. Lovastatin induces a pronounced differentiation response in acute myeloid leukemias. Dimitroulakos J; Thai S; Wasfy GH; Hedley DW; Minden MD; Penn LZ Leuk Lymphoma; 2000 Dec; 40(1-2):167-78. PubMed ID: 11426618 [TBL] [Abstract][Full Text] [Related]
3. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Wu J; Wong WW; Khosravi F; Minden MD; Penn LZ Cancer Res; 2004 Sep; 64(18):6461-8. PubMed ID: 15374955 [TBL] [Abstract][Full Text] [Related]
4. Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo. Lewis KA; Holstein SA; Hohl RJ Leuk Res; 2005 May; 29(5):527-33. PubMed ID: 15755505 [TBL] [Abstract][Full Text] [Related]
5. Statins induce lethal effects in acute myeloblastic leukemia [corrected] cells within 72 hours. Burke LP; Kukoly CA Leuk Lymphoma; 2008 Feb; 49(2):322-30. PubMed ID: 18231920 [TBL] [Abstract][Full Text] [Related]
6. Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells. de Jonge-Peeters SD; van der Weide K; Kuipers F; Sluiter WJ; de Vries EG; Vellenga E Ann Hematol; 2009 Jun; 88(6):573-80. PubMed ID: 19002460 [TBL] [Abstract][Full Text] [Related]
7. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors. Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352 [TBL] [Abstract][Full Text] [Related]
9. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia]. Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396 [TBL] [Abstract][Full Text] [Related]
10. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples. Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245 [TBL] [Abstract][Full Text] [Related]
11. Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by antisense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra). Stosić-Grujicić S; Basara N; Milenković P; Dinarello CA J Chemother; 1995 Feb; 7(1):67-70. PubMed ID: 7629564 [TBL] [Abstract][Full Text] [Related]
12. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. Aref S; Salama O; Al-Tonbary Y; Mansour A Hematology; 2004 Apr; 9(2):113-21. PubMed ID: 15203866 [TBL] [Abstract][Full Text] [Related]
13. Cholesterol based antineoplastic strategies. Lenz M; Miehe WP; Vahrenwald F; Bruchelt G; Schweizer P; Girgert R Anticancer Res; 1997; 17(2A):1143-6. PubMed ID: 9137462 [TBL] [Abstract][Full Text] [Related]
14. Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death. Weidenaar AC; de Jonge HJ; Fidler V; ter Elst A; Meeuwsen-de Boer T; Douwes J; Bouma-ter Steege JC; Hählen K; Kamps WA; de Bont ES Anticancer Drugs; 2008 Jan; 19(1):45-54. PubMed ID: 18043129 [TBL] [Abstract][Full Text] [Related]
15. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Lu C; Hassan HT Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192 [TBL] [Abstract][Full Text] [Related]
16. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia. Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294 [TBL] [Abstract][Full Text] [Related]
17. [Terminal myoglobinuric renal failure in lovastatin therapy with pre-existing chronic renal insufficiency]. Biesenbach G; Janko O; Stuby U; Zazgornik J Wien Klin Wochenschr; 1996; 108(11):334-7. PubMed ID: 8767987 [TBL] [Abstract][Full Text] [Related]
18. The use of alternate-day lovastatin in hypercholesterolemic men. Dennis VC; Britton ML; Sirmans SM; Letassy NA; Freeman DA Ann Pharmacother; 1997 Jun; 31(6):708-12. PubMed ID: 9184709 [TBL] [Abstract][Full Text] [Related]
19. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597 [TBL] [Abstract][Full Text] [Related]